ArticleAnnals of translational medicine2021

Safety profile of poly (ADP-ribose) polymerase (PARP) inhibitors in cancer: a network meta-analysis of randomized controlled trials.

Shengnan Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.